JP2004041099A - Method for producing lactic acid bacterium having immunostimulation effect and immunostimulator - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for producing lactic acid bacteria having high immunostimulation effect by selecting the medium composition of the lactic acid bacteria and to obtain an immunostimulator containing the lactic acid bacteria obtained by the method as an active ingredient. <P>SOLUTION: The lactic acid bacteria having high immunostimulation effect is obtained by culturing lactic acid bacteria in a medium containing corn steep liquor and a casein hydrolyzate. The immunostimulator having excellent effect contains the lactic acid bacteria as the active ingredient. The culture is preferably carried out by keeping the medium at pH 6.5-7.5, the medium contains 1-15 mass % of corn steep liquor and 0.01-5 mass % of the casein hydrolyzate. Preferably the lactic acid bacteria are Enterococcus faecalis and the obtained lactic acid bacteria are heat-treated. <P>COPYRIGHT: (C)2004,JPO

Description

【００４７】
表１から、カゼイン加水分解物を含まないＣＳＬ培地で培養して得られた乳酸菌に比べて、カゼイン加水分解物を含むＣＳＬ培地で培養して得られた乳酸菌は、ＩＬ−１２産生誘導能が非常に高いことが分かる。
【００４８】
【発明の効果】
以上説明したように、本発明によれば、カゼインの加水分解物を添加したＣＳＬ培地を用いて乳酸菌を培養することにより、優れた免疫賦活効果を有する乳酸菌を得ることができる。また、該培地は、非常に安価に調製できるので、乳酸菌の培養コストを低くすることができる。更に、こうして得られた乳酸菌を有効成分として含有させることにより、安全性が高く、優れた免疫賦活効果を有する免疫賦活剤を提供することができる。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to a method for producing a lactic acid bacterium having an immunostimulatory effect and an immunostimulant that can be expected to have an excellent immunostimulatory effect by increasing the amount of cytokine production in a living body by ingestion.
[0002]
[Prior art]
Lactic acid bacteria are known to have the effect of improving the immune activity of the living body (immunostimulatory effect) in addition to the effect of improving the balance of intestinal flora to reduce intestinal spoilage products and stool properties. In general, in order to obtain the above physiological effect by lactic acid bacteria, it is said that it is necessary to ingest a relatively large amount of bacterial cells.
[0003]
On the other hand, various culture media are used for culturing lactic acid bacteria. Usually, nutrient-rich media including yeast extract, peptone, meat extract and the like are used to improve the growth of lactic acid bacteria.
[0004]
[Problems to be solved by the invention]
However, the relationship between the immunostimulatory effect of lactic acid bacteria and the medium composition has not been studied so far, and the medium composition has been selected only focusing on the growth characteristics of lactic acid bacteria.
[0005]
In addition, if a nutrient-rich medium is used, it is easily thought that lactic acid bacteria will grow more, but when trying to cultivate lactic acid bacteria industrially in large quantities, using a nutrient-rich medium as described above, There was a problem that the cost of the medium would be very high.
[0006]
On the other hand, a medium (corn steep liquor medium) using corn steep liquor, which is a by-product when producing corn starch, is well known as an inexpensive medium, but nothing is known about the relationship with the immunostimulatory effect of lactic acid bacteria. It wasn't.
[0007]
Accordingly, an object of the present invention is to provide a method for producing a lactic acid bacterium having a high immunostimulatory effect by selecting a medium composition of the lactic acid bacterium, and an immunostimulant containing the lactic acid bacterium obtained by the method as an active ingredient. There is.
[0008]
[Means for Solving the Problems]
As a result of earnest research to achieve the above object, the present inventors have found that lactic acid bacteria having a high immunostimulatory effect can be obtained by culturing lactic acid bacteria in a corn steep liquor medium to which a casein hydrolyzate is added, The present invention has been completed.
[0009]
That is, the method for producing lactic acid bacteria having an immunostimulatory effect of the present invention is characterized by culturing lactic acid bacteria using a medium containing corn steep liquor and a casein hydrolyzate.
[0010]
According to the present invention, lactic acid bacteria having a high immunostimulatory effect can be obtained at low cost by culturing lactic acid bacteria using a corn steep liquor medium to which a casein hydrolyzate is added.
[0011]
In the method for producing lactic acid bacteria of the present invention, the culture is preferably carried out while maintaining the pH of the medium at 6.5 to 7.5. As a result, it is possible to prevent a decrease in the growth of lactic acid bacteria accompanying a decrease in pH and increase productivity.
[0012]
Moreover, it is preferable that the said culture medium contains 1-15 mass% of corn steep liquor, and 0.01-5 mass% of the hydrolyzate of casein. Thereby, lactic acid bacteria having a higher immunostimulatory effect can be obtained.
[0013]
Furthermore, the casein hydrolyzate is preferably obtained by degrading casein using two or more kinds of proteases. In this case, it is preferable to use alkaline protease and neutral protease as the protease. This makes it possible to obtain peptides and amino acids that are easily used as nutrient sources for lactic acid bacteria.
[0014]
Furthermore, it is preferable that the lactic acid bacterium is Enterococcus faecalis . In addition, it is preferable to collect lactic acid bacteria from the culture and sterilize by heating. According to this, lactic acid bacteria having a higher immunostimulatory effect can be obtained, and safety when used as a raw material for foods and pharmaceuticals can be further increased.
[0015]
According to the present invention, lactic acid bacteria having a high immunostimulatory effect can be obtained at low cost by culturing lactic acid bacteria using a corn steep liquor medium to which a casein hydrolyzate is added.
[0016]
DETAILED DESCRIPTION OF THE INVENTION
First, the medium used in the method for culturing lactic acid bacteria of the present invention will be described. Corn steep liquor (hereinafter abbreviated as CSL) is a concentrated product of the immersion liquid obtained in the raw material (corn) dipping process during the production process of corn starch. Is included. CSL is generally used as a medium component, and commercially available products can be used.
[0017]
The casein hydrolyzate may be a commercially available product, or may be prepared by enzymatic degradation or acid hydrolysis of casein. In the present invention, it is preferable to use a casein prepared by hydrolysis using two or more enzymes. The casein hydrolyzate thus obtained contains a large amount of peptides and amino acids that are easily decomposed as a nutrient source for lactic acid bacteria.
[0018]
The enzymatic degradation of casein is preferably performed, for example, as follows. That is, after suspending casein in water, the pH is adjusted to 9 to 10, and 0.05 to 5% by mass of an alkaline protease is added to the substrate, at the optimum enzyme temperature (40 to 70 ° C.). After reacting for 0.5 to 5 hours, the pH of the reaction solution is adjusted to 6.5 to 7.5, and 0.05 to 5% by mass of neutral protease is added to the substrate to optimize the enzyme. What is necessary is just to make it react at temperature (35-50 degreeC) for 0.5 to 24 hours.
[0019]
The alkaline protease can be used without particular limitation as long as it is an enzyme or an enzyme preparation that can be used in food production. For example, the trade name “Aroase XA-10” (manufactured by Yakult Pharmaceutical Co., Ltd.), the trade name “Orientase 22BF”. (Trade name “Alcalase” (manufactured by Novo Industry), trade name “Samoase” (manufactured by Yamato Kasei), etc. can be used.
[0020]
The neutral protease can be used without particular limitation as long as it is an enzyme or an enzyme preparation that can be used in food production. For example, the trade name “punchitase HP”, the trade name “punchitase AP”, the trade name “punchitase” NP-2 "(all manufactured by Yakult Pharmaceutical Co., Ltd.), trade name" Orientase ONS "(manufactured by Hankyu Bioindustry), trade name" Nutrase "(manufactured by Novo Industry), and the like can be used.
[0021]
In the present invention, it is preferable to use a medium containing 1 to 15% by mass of CSL and 0.01 to 5% by mass of hydrolyzate of casein, and 5 to 10% by mass of CSL and 0 to 0% of hydrolyzed casein. It is more preferable to use a medium containing 2 to 0.5% by mass. If the content of CSL and casein hydrolyzate is too small, good growth of lactic acid bacteria cannot be expected, and lactic acid bacteria having sufficient immunostimulatory effect, that is, IL-12 production inducing ability cannot be obtained. On the other hand, if the content of CSL and casein hydrolyzate is too large, when lactic acid bacteria are collected, precipitates derived from the medium components are mixed, so that pure cells may not be obtained.
[0022]
In addition to the above basic components, sugar sources such as lactose, glucose and dextrin, inorganic components such as phosphate, soy protein (including hydrolysates thereof) and the like may be added as necessary. . Among the above components, it is preferable to add 1 to 10% by mass of lactose and 0.1 to 1% by mass of phosphate. Yeast extract, peptone, meat extract and the like may be added as necessary, but are not preferable because of high cost.
[0023]
The medium used in the present invention can be prepared according to a conventional method using each of the above components. For example, a predetermined amount of CSL and casein hydrolyzate are added to water (preferably distilled water or ion-exchanged water). Then, if necessary, the above-mentioned other components are further added and dissolved uniformly, and then the pH is adjusted to 6.5 to 7.0 and sterilized by a known method (for example, an autoclave).
[0024]
The culture method of the present invention may be carried out by culturing lactic acid bacteria according to a conventional method using the medium prepared as described above. For example, a colony of lactic acid bacteria cultured in a lactic acid bacteria preculture solution (or an agar medium) ) And incubating at 30 to 45 ° C. for 12 to 72 hours under aerobic, microaerobic or anaerobic conditions. During culture, the pH of the medium is lowered by lactic acid bacteria metabolites (such as lactic acid). Therefore, the pH of the medium is appropriately measured, and an alkaline aqueous solution (aqueous solution of sodium hydroxide, potassium hydroxide, calcium hydroxide, etc.) It is preferable to carry out the culture while maintaining the pH of the medium at 6.5 to 7.5 (more preferably pH 6.8 to 7.2). Thus, by culturing while maintaining the pH of the medium in the vicinity of neutrality, the growth of lactic acid bacteria can be improved, and the bacterial cell yield can be improved.
[0025]
The lactic acid bacteria used in the method of culturing the invention having, for example, Enterococcusfaecalis, Enterococcus faecium, Lactobacillus acidophilus , Lactobacillus casei, Lactobacillus lactis, Bifidobacterium Longum, Bifidobacterium breve, although Streptococcus thermophilus and the like preferably, a stronger immunostimulatory effect Enterococcus faecalis (ATCC 19433, ATCC 14508, ATCC 23655, IFO 16803, etc.) is particularly preferred.
[0026]
In the present invention, after culturing of lactic acid bacteria, it is preferable to collect lactic acid bacteria cells from the obtained culture by a method such as filtration or centrifugation, and to sterilize these bacteria by heating. As a result, lactic acid bacteria with higher safety can be provided as a raw material for foods and pharmaceuticals, and the immunostimulatory effect is not reduced even when killed by heat sterilization. The sterilized cells are preferably dried and powdered to produce a product as a raw material for foods and pharmaceuticals.
[0027]
The immunostimulant of the present invention contains the lactic acid bacterium as an active ingredient. Such an immunostimulant is a powder, granule, tablet, capsule, pasty or liquid beverage by adding excipients, sweeteners, acidulants, vitamins, minerals, etc., if necessary, to the lactic acid bacteria. Can be prepared as
[0028]
The effective intake of the immunostimulant of the present invention is 1 mg to 10 g per day for an adult in terms of lactic acid bacteria, and more preferably 50 to 500 mg.
[0029]
Moreover, the immunostimulant of this invention can also be ingested by adding to a drink, a jelly, a candy, a gum, a retort food, an instant food etc., for example. In this case, it is preferable to add the lactic acid bacteria to the foods so that 1 to 1000 mg, more preferably 10 to 500 mg, can be taken per day.
[0030]
【Example】
Hereinafter, the present invention will be specifically described with reference to examples.
[0031]
Example 200 g of casein was suspended in 2 L of water, adjusted to pH 10 with caustic soda, 1.0 g of Samoaze (trade name, manufactured by Taisei Kasei) was added, and the mixture was reacted at 70 ° C. for 4 hours. Then, after adjusting the pH of the reaction solution to 7.0 with hydrochloric acid, 1.0 g of punchase NP-2 (trade name, manufactured by Yakult Pharmaceutical Co., Ltd.) was added and reacted at 50 ° C. for 4 hours. The obtained reaction solution was heat-treated to inactivate the enzyme to obtain a casein hydrolyzed solution.
[0032]
Add 0-0.75L of the above casein hydrolyzate (0-75g of casein hydrolyzate) to 0.25L of 20% CSL solution, and add ion-exchanged water so that the total amount becomes 1L. After adjusting to 0.0, each medium was prepared by autoclaving and varying the concentration of casein hydrolyzate.
[0033]
To each medium, an appropriate amount of a pre-culture solution of lactic acid bacteria ( Enterococcus faecalis ATCC 19433) was added and cultured at 37 ° C. for 24 hours while adjusting the pH of the culture solution to 7.0 ± 0.1 with caustic soda using a pH stat. Was done.
[0034]
After completion of the culture, the culture solution was centrifuged to collect the cells and washed with water, then suspended in water, heat-treated at 80 to 115 ° C. for 30 minutes to 3 seconds, and freeze-dried to obtain heat-treated cells.
[0035]
And the immunostimulation effect was measured with the following method using the heat-treated microbial cell of each obtained lactic acid bacterium. The immunostimulatory effect was determined using IL-12 production inducing ability as an index.
[0036]
(1) Preparation of macrophages ICR mice (male) of 4-8 weeks old were intraperitoneally injected with 0.4 mL / mouse of glycerol solution at a concentration of 1 g / 100 mL. After slaughtering and injecting 5 mL / mouse of PBS cooled in the abdominal cavity and swallowing the abdomen well, the intraperitoneal fluid (about 4 mL) was taken out with a syringe, placed in a silicon-coated Spitz tube, 1200 rpm, 5 Centrifuge for minutes.
[0037]
Then, after removing the supernatant and red blood cells on the wall, cold PBS was added and pipetting was performed, and centrifugation was performed at 800 rpm for 5 minutes to remove the supernatant and red blood cells on the wall. This operation was further repeated once. Finally, 1 mL / mouse of 1% FCS-added ET-RPMI1640 Medium (manufactured by Invitrogen, the same applies hereinafter) was added to suspend the cells. To 50 μL of this cell suspension, 50 μL of Cherk staining solution was added and mixed, and the number of viable cells was counted using a red blood cell counter. Based on the calculated viable cell count, 1% FCS-added ET-RPMI1640 Medium was added to the cell suspension to adjust the cell count to 1 × 10 ⁶ / mL to obtain a macrophage fluid.
[0038]
Then, 200 μL / well of the macrophage solution was placed in a 96-well flat bottom plate and cultured in a CO ₂ incubator for 1.5 to 5 hours.
[0039]
Reagent PBS: NaCl 80 g, Na ₂ HPO ₄ · 12H ₂ O 29 g, KCl 2 g, KH ₂ PO ₄ 2 g are dissolved in distilled water to 1 L, and sterilized by autoclave.
[0040]
FCS (Fetal Calf Serum): Frozen FCS is put into a 56 ° C. water bath for 40 minutes to inactivate, ice-cooled, passed through a 70 μm cell strainer, put into a sterilized container, and stored in a refrigerator.
[0041]
_{ET-RPMI1640 Mediumu: RPMI1640 31.2g,} NaHCO 3 3.75g, penicillin G-K (trade name, Banyu Pharmaceutical Co., Ltd., millions) 0.18g, kanamycin 0.18g, was dissolved in water for injection 3L After blowing CO ₂ gas, the solution is filtered with a 0.45 μm filter.
[0042]
Turku staining solution: 0.01% gentian violet aqueous solution: acetic acid: water = 1: 1: 98, and refrigerated.
[0043]
(2) Preparation of bacterial cell dispersion After preparing each heat-treated bacterial cell to 1 mg / mL with 5% FCS-added ET-RPMI1640 Medium, ultrasonic treatment is performed to disperse the bacterial cell and disperse the bacterial cell. A liquid was obtained. This bacterial cell dispersion was diluted 100-fold with 5% FCS-added ET-RPMI1640 Medium, placed in a 96-well U-shaped plate at 250 μL / well, and incubated in a CO ₂ incubator for 1 hour.
[0044]
(3) Induction of IL-12 After removing the supernatant from the pre-incubated 96-well flat-bottom plate of (1) above and washing twice with PBS kept at 37 ° C., the pre-incubated bacteria of (2) above 200 μL of the body dispersion was added and cultured in a CO ₂ incubator for exactly 2 hours to induce IL-12.
[0045]
IL-12 was measured using a mouse IL-12 measurement kit (trade name “Cytoscreen”, manufactured by BIO SOURCE INTERNATIONAL). The results are shown in Table 1.
[0046]
[Table 1]

[0047]
From Table 1, lactic acid bacteria obtained by culturing in a CSL medium containing casein hydrolyzate have an ability to induce IL-12 production, compared to lactic acid bacteria obtained by culturing in a CSL medium not containing casein hydrolyzate. You can see that it is very expensive.
[0048]
【The invention's effect】
As described above, according to the present invention, lactic acid bacteria having an excellent immunostimulatory effect can be obtained by culturing lactic acid bacteria using a CSL medium supplemented with a casein hydrolyzate. Further, since the medium can be prepared at a very low cost, the culture cost of lactic acid bacteria can be reduced. Furthermore, by containing the lactic acid bacteria thus obtained as an active ingredient, it is possible to provide an immunostimulator having high safety and an excellent immunostimulatory effect.

Claims (8)

A method for producing a lactic acid bacterium having an immunostimulatory effect, wherein the lactic acid bacterium is cultured using a medium containing a corn steep liquor and a casein hydrolyzate. The method for producing lactic acid bacteria having an immunostimulatory effect according to claim 1, wherein the culture is performed while maintaining the pH of the medium at 6.5 to 7.5. The method for producing lactic acid bacteria having an immunostimulatory effect according to claim 1 or 2, wherein the medium contains 1 to 15% by mass of corn steep liquor and 0.01 to 5% by mass of a hydrolyzate of casein. . The method for producing lactic acid bacteria having an immunostimulatory effect according to any one of claims 1 to 3, wherein the casein hydrolyzate is obtained by degrading casein using two or more types of proteases. The method for producing lactic acid bacteria having an immunostimulatory effect according to claim 4, wherein alkaline protease and neutral protease are used as the protease. The method for producing a lactic acid bacterium having an immunostimulatory effect according to any one of claims 1 to 5, wherein the lactic acid bacterium is Enterococcus faecalis . The method for producing a lactic acid bacterium having an immunostimulatory effect according to claim 1, wherein lactic acid bacteria are collected from the culture and sterilized by heating. An immunostimulant comprising the lactic acid bacterium obtained by the method according to claim 1 as an active ingredient.